New Economic Analysis Highlights Cost-Effectiveness of BLC Over NBI Imaging for Bladder Cancer Treatment#Norway#Oslo#Bladder_Cancer#Photocure_ASA#BLC_Imaging
New Economic Analysis Highlights Cost-Effectiveness of BLC Over NBI Imaging for Bladder Cancer Treatment
A recent study published in 'The Journal of Medical Economics' reveals that Blue Light Cystoscopy (BLC) is more cost-effective than Narrow Band Imaging (NBI) for bladder cancer treatment.
third-news.com
May 4, 2026 at 6:37 AM
New Economic Analysis Highlights Cost-Effectiveness of BLC Over NBI Imaging for Bladder Cancer Treatment#Norway#Oslo#Bladder_Cancer#Photocure_ASA#BLC_Imaging